Similar companies
| Company | Transaction Value | |
|---|---|---|
![]() |
OcugenOCGN |
$78,000 |
![]() |
AmarinAMRN |
$520,000 |
![]() |
Gilead SciencesGILD |
-$2.35B |
![]() |
Anavex Life SciencesAVXL |
-$6.3M |
![]() |
AmgenAMGN |
-$169M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Hamilton James C | Jan 5, 2026 | Sell | 14,792 | $63.01 | $930,000 |
| Hamilton James C | Jan 5, 2026 | Sell | 12,711 | $63.95 | $810,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 13,451 | $62.96 | $850,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 11,842 | $63.84 | $760,000 |
| Hamilton James C | Jan 5, 2026 | Sell | 6,090 | $62.28 | $380,000 |
| Hamilton James C | Jan 5, 2026 | Sell | 4,625 | $61.24 | $280,000 |
| Hamilton James C | Jan 5, 2026 | Sell | 1,200 | $64.49 | $77,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 6,164 | $62.23 | $380,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 5,873 | $62.91 | $370,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 4,368 | $61.2 | $270,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 2,700 | $64.44 | $170,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 2,336 | $64.04 | $150,000 |
| Hamilton James C | Jan 5, 2026 | Sell | 437 | $65.97 | $29,000 |
| Hamilton James C | Jan 5, 2026 | Sell | 309 | $68 | $21,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 900 | $62.25 | $56,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 600 | $61.12 | $37,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 313 | $68 | $21,000 |
| O'Brien Patrick | Jan 5, 2026 | Sell | 46 | $68 | $3,100 |
| Anzalone Christopher Richard | Jan 2, 2026 | Sell | 7,416 | $65.88 | $490,000 |
| Anzalone Christopher Richard | Jan 2, 2026 | Sell | 5,771 | $66.39 | $380,000 |
| Anzalone Christopher Richard | Dec 29, 2025 | Sell | 35,181 | $69.33 | $2.4M |
| Anzalone Christopher Richard | Dec 29, 2025 | Sell | 16,545 | $68.69 | $1.1M |
| Ferrari Mauro | Dec 26, 2025 | Sell | 7,530 | $70 | $530,000 |
| Anzalone Christopher Richard | Dec 22, 2025 | Sell | 10,012 | $68.33 | $680,000 |
| Anzalone Christopher Richard | Dec 22, 2025 | Sell | 2,574 | $68.85 | $180,000 |
| Vakiener Victoria | Dec 19, 2025 | Sell | 5,281 | $67.97 | $360,000 |
| Vakiener Victoria | Dec 19, 2025 | Sell | 2,799 | $66.63 | $190,000 |
| Vakiener Victoria | Dec 19, 2025 | Sell | 1,960 | $68.39 | $130,000 |
| Waddill William D. | Dec 19, 2025 | Sell | 5,451 | $68.01 | $370,000 |
| Waddill William D. | Dec 19, 2025 | Sell | 2,416 | $66.66 | $160,000 |
| Anzalone Christopher Richard | Dec 19, 2025 | Sell | 8,147 | $68.01 | $550,000 |
| Anzalone Christopher Richard | Dec 19, 2025 | Sell | 3,979 | $66.67 | $270,000 |
| Anzalone Christopher Richard | Dec 19, 2025 | Sell | 1,319 | $68.48 | $90,000 |
| OLUKOTUN ADEOYE Y | Dec 19, 2025 | Sell | 6,083 | $68.04 | $410,000 |
| OLUKOTUN ADEOYE Y | Dec 19, 2025 | Sell | 3,090 | $66.7 | $210,000 |
| Waddill William D. | Dec 19, 2025 | Sell | 500 | $68.53 | $34,000 |
| OLUKOTUN ADEOYE Y | Dec 19, 2025 | Sell | 827 | $68.48 | $57,000 |
| Anzalone Christopher Richard | Dec 17, 2025 | Sell | 46,287 | $63.55 | $2.9M |
| Anzalone Christopher Richard | Dec 17, 2025 | Sell | 35,750 | $64.51 | $2.3M |
| Anzalone Christopher Richard | Dec 17, 2025 | Sell | 1,981 | $66.3 | $130,000 |
| Anzalone Christopher Richard | Dec 17, 2025 | Sell | 982 | $65.53 | $64,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 14,095 | $62.12 | $880,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 10,963 | $61.25 | $670,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 8,476 | $62.94 | $530,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 8,416 | $60.51 | $510,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 6,661 | $64.29 | $430,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 3,221 | $67.87 | $220,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 1,300 | $65.77 | $86,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 1,000 | $64.96 | $65,000 |
| Anzalone Christopher Richard | Dec 16, 2025 | Sell | 166 | $66.77 | $11,000 |
| Anzalone Christopher Richard | Dec 15, 2025 | Sell | 100,532 | $68.67 | $6.9M |
| Anzalone Christopher Richard | Dec 15, 2025 | Sell | 21,321 | $69.28 | $1.5M |
| Anzalone Christopher Richard | Dec 15, 2025 | Sell | 8,147 | $69.96 | $570,000 |
| PERRY MICHAEL S | Dec 5, 2025 | Sell | 16,250 | $61.03 | $990,000 |
| Ferrari Mauro | Nov 28, 2025 | Sell | 8,750 | $56.39 | $490,000 |
| Hamilton James C | Oct 1, 2025 | Sell | 20,000 | $35 | $700,000 |
| Hamilton James C | Sep 12, 2025 | Sell | 15,000 | $30 | $450,000 |
| Hamilton James C | Sep 2, 2025 | Sell | 15,000 | $25 | $380,000 |
| Hamilton James C | Aug 15, 2025 | Sell | 9,389 | $20 | $190,000 |
| Hamilton James C | Aug 13, 2025 | Sell | 611 | $20 | $12,000 |
| Anzalone Christopher Richard | Apr 11, 2025 | Sell | 50,800 | $11.49 | $580,000 |
| Anzalone Christopher Richard | Apr 10, 2025 | Sell | 50,000 | $10.87 | $540,000 |
| Anzalone Christopher Richard | Apr 9, 2025 | Sell | 35,305 | $9.93 | $350,000 |
| Anzalone Christopher Richard | Apr 9, 2025 | Sell | 3,400 | $10.75 | $37,000 |
| Anzalone Christopher Richard | Apr 9, 2025 | Sell | 1,617 | $11.76 | $19,000 |
| Anzalone Christopher Richard | Mar 13, 2025 | Sell | 51,425 | $15.07 | $770,000 |
| Anzalone Christopher Richard | Mar 4, 2025 | Sell | 133,333 | $17.02 | $2.3M |
| Anzalone Christopher Richard | Mar 3, 2025 | Sell | 166,667 | $18.03 | $3M |
| OLUKOTUN ADEOYE Y | Jan 23, 2025 | Sell | 959 | $21 | $20,000 |
| Myszkowski Kenneth Allen | Jan 7, 2025 | Sell | 10,000 | $19.69 | $200,000 |
| O'Brien Patrick | Jan 7, 2025 | Sell | 8,000 | $19.69 | $160,000 |
| Myszkowski Kenneth Allen | Jan 7, 2025 | Sell | 8,000 | $19.7 | $160,000 |
| Hamilton James C | Jan 6, 2025 | Sell | 21,758 | $19.68 | $430,000 |
| Hamilton James C | Jan 6, 2025 | Sell | 10,971 | $20.11 | $220,000 |
| O'Brien Patrick | Jan 6, 2025 | Sell | 19,658 | $19.69 | $390,000 |
| Myszkowski Kenneth Allen | Jan 6, 2025 | Sell | 17,765 | $19.68 | $350,000 |
| O'Brien Patrick | Jan 6, 2025 | Sell | 9,526 | $20.1 | $190,000 |
| Myszkowski Kenneth Allen | Jan 6, 2025 | Sell | 9,402 | $20.1 | $190,000 |
| Anzalone Christopher Richard | Jan 2, 2025 | Sell | 11,520 | $19.05 | $220,000 |
| OLUKOTUN ADEOYE Y | Dec 27, 2024 | Sell | 2,850 | $20 | $57,000 |
| Anzalone Christopher Richard | Dec 23, 2024 | Sell | 12,563 | $19.59 | $250,000 |
| Anzalone Christopher Richard | Dec 18, 2024 | Sell | 12,653 | $20.52 | $260,000 |
| Anzalone Christopher Richard | Dec 18, 2024 | Sell | 8,260 | $21.74 | $180,000 |
| Anzalone Christopher Richard | Dec 18, 2024 | Sell | 5,799 | $22.12 | $130,000 |
| Waddill William D. | Dec 17, 2024 | Sell | 3,747 | $22.04 | $83,000 |
| GIVEN DOUGLAS B | Dec 17, 2024 | Sell | 547 | $22.04 | $12,000 |
| Waddill William D. | Dec 16, 2024 | Sell | 3,748 | $21.9 | $82,000 |
| GIVEN DOUGLAS B | Dec 16, 2024 | Sell | 5,000 | $21.9 | $110,000 |
| Vakiener Victoria | Dec 16, 2024 | Sell | 8,994 | $21.91 | $200,000 |
| Oliver Tracie | Jul 2, 2024 | Sell | 9,394 | $25.28 | $240,000 |
| Vakiener Victoria | May 2, 2024 | Sell | 1,799 | $23.31 | $42,000 |
| Lu Hongbo | Apr 18, 2024 | Buy | 500 | $22 | $11,000 |
| Lu Hongbo | Apr 2, 2024 | Buy | 150 | $27.34 | $4,100 |
| Hamilton James C | Apr 1, 2024 | Sell | 6,000 | $28.03 | $170,000 |
| Lu Hongbo | Mar 26, 2024 | Buy | 850 | $27.5 | $23,000 |
| Lu Hongbo | Mar 22, 2024 | Buy | 400 | $28 | $11,000 |
| Lu Hongbo | Mar 20, 2024 | Buy | 1,000 | $27.5 | $28,000 |
| Myszkowski Kenneth Allen | Mar 6, 2024 | Sell | 40,000 | $35.19 | $1.4M |
FAQ - Insider Transactions
The most recent insider transaction for Arrowhead Pharmaceuticals was conducted by Hamilton James C, who sold 14,792 shares on January 5, 2026 at a price of $63.01 per share.
Lu Hongbo has bought the most ARWR stock in the last 2 years, with a total value of $77,000.
Anzalone Christopher Richard has sold the most ARWR stock in the last 2 years, with a total value of $33M.
The total value of insider transactions for Arrowhead Pharmaceuticals in the last 2 years is negative, amounting to -$49M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Arrowhead Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.




